A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic

Gunhild Lien1, Anne M Selvaag, Berit Flatø

  • 1Rikshospitalet University Hospital, Oslo, Norway. gunhild.lien@chello.no <gunhild.lien@chello.no>

Insights

Children with juvenile idiopathic arthritis (JIA) experience reduced bone mass gains and lean mass early in the disease. Weight-bearing activity and bone turnover markers predict bone mass changes in JIA patients.

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Endocrinology
  • Bone Metabolism

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children.
  • Bone health is a significant concern in JIA due to potential long-term consequences.
  • Early identification of bone mass reduction predictors is crucial for intervention.

Purpose of the Study:

  • To investigate early bone mass changes in children with JIA.
  • To identify predictors of bone mass reduction in pediatric JIA patients.
  • To differentiate bone mass trajectories between JIA patients and healthy controls.

Main Methods:

  • Prospective cohort study matching 108 children with early JIA to 108 healthy controls.
  • Assessment of bone mineral density, bone mineral content, body composition, and growth at baseline and 24-month follow-up.
  • Analysis of biochemical markers of bone turnover and weight-bearing activities.

Main Results:

  • JIA patients showed significantly lower gains in total body bone mineral content and lean mass compared to healthy children.
  • Reduced bone formation, bone resorption, and weight-bearing activities were noted in JIA patients.
  • Serum bone-specific alkaline phosphatase, C-telopeptide of type I collagen, and weight-bearing activities predicted total body bone mineral content changes in JIA.

Conclusions:

  • Children with JIA exhibit moderate reductions in bone mass accrual and lean mass early in their disease course.
  • Bone turnover and weight-bearing activities are significantly impacted in early JIA.
  • Specific biochemical markers and physical activity levels are key predictors of bone health in pediatric JIA.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...